Frequently Asked Questions
First in Human efficacy data at a fixed price
VC Ready. Proof of Concept. Fixed Scope. Agreed Timelines.
The "SaaP" Model: FIH, PoC, VC-Ready Concept
What exactly is "Service as a Product" (SaaP) in clinical trials
Traditional CRO models rely on complex hourly billing and variable scope. SaaP turns the clinical trial into a fixed-scope, fixed priced product. You buy a specific outcome (e.g., "First-in-Human Eficacy Data") for a fixed price
Why would I choose a "standardized" trial over a custom one?
Speed and certainty. Custom trials take months to negotiate. Our SaaP packages use pre-validated protocols and high-performance sites, allowing you to start months earlier. For 80% of early-stage innovations, standard safety requirements are identical.
Pricing & "Hidden Costs"
Is the price really fixed? What about "scope creep"?
The Core Product price is fixed for the scope defined. We solved "scope creep" with "Essential Add-On” Packs. You can add fixed-price bundles for Medical Writing, Data Systems, and Labs upfront, giving you 100% budget certainty.
What if my study requires more than the standard number of patients?
The base packages cover the specific subject counts listed (e.g., 18 for Pharma). If you need more subjects—for example, to add a Multiple Ascending Dose (MAD) cohort—we offer a fixed-price "MAD Expansion Pack" that seamlessly upgrades your study.
Will the affordable costs of your TTT trials mean that there is no fixed timeline or compromises in quality?
Our CRO partners (Tigermed EMEA, Vantage, and others) are known for trials performed at maximum speed (or, at „expedited pace“) and we will agree with you on the overall timeline and deliverables. Our QA system guarantees that we always work at highest quality, our due diligence ensures patient safety and high quality of trial data.
Regulatory Strategy & Geography
Which country will my trial be conducted in?
To keep the price low and speed high, Try The Trial selects the best "Regulatory Bridge" country for your therapy. These are typically regions fully compliant with FDA/EMA data standards but with faster startup times.
What if my investors require the study to be in the USA or Western Europe?
You can purchase the "Tier-1 Geo Unlock" upgrade. This allows you to select a specific Tier-1 geography while keeping the standardized "SaaP" operational model.
For the Pharma/Neuro packages, is 18-20 subjects enough for Phase 1?
These packages deliver Phase 1a (Single Ascending Dose) data. For many startups, this is the data needed to raise Series A. If you require a "full" Phase 1 (including Multiple Ascending Dose), simply add the "MAD Expansion Pack" to your order.
Execution Risks & Safety
Fixed price is great, but how do you guarantee patient recruitment?
We utilize a pre-vetted network of sites that have already committed to these therapeutic areas. If a site underperforms, Try The Trial activates backup sites from our global network at no additional cost. We absorb the operational risk.
What if my drug shows toxicity and we have to stop early?
We stop at milestone achieved.
Who is actually monitoring patient safety?
Every SaaP study includes a dedicated Medical Monitor from our CRO partners' global safety unit. We standardize the process, not the safety judgment.
The Future (Phase 2)
Do I have to switch CROs for Phase 2?
TBD
Can I take the data to another CRO if I want?
Yes. You own the data. It is exported in standard format, so you are free to take your package to any partner without being held hostage.
in partnership with
a product of
